Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fructus Rosa Roxburghii refers specifically to the fruit of Rosa roxburghii Tratt, a plant native to China, traditionally consumed as food and used in medicinal practices. The fruit contains a wide range of bioactive compounds, including high levels of vitamin C, flavonoids (e.g., catechin, quercetin), phenolic acids (e.g., gallic acid, protocatechuic acid), polysaccharides, triterpenoids, and tannins. Pharmacological studies show multiple biological activities: strong antioxidant properties, \u03b1-glucosidase inhibition (implicating possible anti-diabetic action), regulation of blood glucose and lipid metabolism, immunomodulatory and anti-inflammatory effects, and apparent anti-tumor effects. The mechanism of action is primarily attributed to the scavenging of free radicals, inhibition of digestive enzymes (notably \u03b1-glucosidase and \u03b1-amylase), and modulation of metabolic pathways in glucose and lipid homeostasis. It is widely used in functional foods and dietary supplements, especially those targeting metabolic health and general well-being[1][3][4][6][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fructus rosa roxburghii.